In MYCN-amplified NB cell lines, combination treatment was associated with downregulation of MYCN gene expression and N-myc protein expression, downregulation of DNA repair proteins, accumulation of p53 and DNA damage, and induction of apoptosis. The gene discussed is XRCC6P5; the disease is neuroblastoma.